ResearcherStiftung CharitéNo recent work listed
Hubert G. Hotz
Matched on OpenAlex author ID A5110503726. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 3
2011: 1 paper · 2012: none · 2013: none · 2014: 2 papers
Papers 3
- Taurolidine induces epithelial-mesenchymal transition via up-regulation of the transcription factor Snail in human pancreatic cancer cell lines. Last author DOI 10.1007/s00384-014-1998-4↗
- Non-invasive quantification of anti-angiogenic therapy by contrast-enhanced MRI in experimental pancreatic cancer. Last author DOI 10.1177/0284185113493776↗
- Genes associated with epithelial-mesenchymal transition: possible therapeutic targets in ductal pancreatic adenocarcinoma? Co-author DOI 10.2174/187152011795677436↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Birgit Hotz · 3 shared papers, 2011–2014 · strength 0.15
- Paper Taurolidine induces epithelial-mesenchymal transition via up-regulation of the transcription factor Snail in human panc… DOI 10.1007/s00384-014-1998-4↗
- Paper Non-invasive quantification of anti-angiogenic therapy by contrast-enhanced MRI in experimental pancreatic cancer. DOI 10.1177/0284185113493776↗
- Paper Genes associated with epithelial-mesenchymal transition: possible therapeutic targets in ductal pancreatic adenocarcino… DOI 10.2174/187152011795677436↗
- Heinz Johannes Buhr · 3 shared papers, 2011–2014 · strength 0.15
- Paper Taurolidine induces epithelial-mesenchymal transition via up-regulation of the transcription factor Snail in human panc… DOI 10.1007/s00384-014-1998-4↗
- Paper Non-invasive quantification of anti-angiogenic therapy by contrast-enhanced MRI in experimental pancreatic cancer. DOI 10.1177/0284185113493776↗
- Paper Genes associated with epithelial-mesenchymal transition: possible therapeutic targets in ductal pancreatic adenocarcino… DOI 10.2174/187152011795677436↗
- Hans‐Juergen Raatschen · 1 shared paper, 2014 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.